Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Submitted by
admin
on November 27, 2015 - 11:59am
Source:
Seeking Alpha
News Tags:
Novo Nordisk
diabetes
semaglutide
GLP-1 agonist
Headline:
Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Do Not Allow Advertisers to Use My Personal information
